← Evidence map

ArticleTheranostics2025

Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcoma.

Xuekun Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39744222